crystallization in polymorphic systems - school of pharmacy · crystallization in polymorphic...

18
Crystallization in polymorphic systems Lian Yu University of Wisconsin – Madison, School of Pharmacy and Department of Chemistry With thanks to PRF, NSF Polymorphs of Carbon Hard Electrical insulator Soft Semi-metal Soft Conductive Polymorphs serve two goals of chemical research: Finding new materials Learning structure-property relations

Upload: dinhtram

Post on 28-Feb-2019

223 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

Crystallization in polymorphic systems

Lian YuUniversity of Wisconsin – Madison,

School of Pharmacy and Department of Chemistry

With thanks toPRF, NSF

Polymorphs of Carbon

HardElectrical insulator

SoftSemi-metal

SoftConductive

Polymorphs serve two goals of chemical research:Finding new materialsLearning structure-property relations

Page 2: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

Polymorphs of ROY

(1) R P-1mp 106.2 oC= 21.7° ROY

(6) ORP Pbcamp 97 ºC, = 39.4°

(4) OP P21/cmp 112.7 oC= 46.1°

(2) ON P21/cmp 114.8oC= 52.6°

(5) YN P-1, mp 99 ºC= 104.1°

(3) Y P21/cmp 109.8 oC= 104.7°

N

S

HNO O

C

N

CH3

J. Am. Chem. Soc.2000, 122, 585

100 m

Y04

R

RL

JACS 2005a

(9) YT04 P21/cmp 106.9oC = 112.8°

(7) RPL

JACS 2001

(8) Y04

R05

Y04

L

(10) R05

JACS 2005b

“Non-polymorphic” systems

naphthalene

COOH OHO

HOOH

OH

O

OH

O OH

OH

OH

sucrosebenzoic acid

Page 3: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

Polymorphs of drugs have different bioavailability

Polymorphs have been used to test the third law of thermodynamics

Westrum & McCullough (1963)

Page 4: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

… and other structure-property relations

Solution or melt no reactionh

G. Schmidt and workers before him

The problem of controlling polymorphism: Crystallizing from the same liquid, which

polymorph “wins”?

A B

liquid

C

Page 5: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

This talkCrystallization in polymorphic systems

(1) A new mechanism: Nucleation of one polymorph by another

(2) Hidden polymorph discovered by cross-nucleation

(3) Survival of the fittest polymorph: Fast nucleater vs. fast grower

Crystallization = nucleation + growth

Page 6: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

least stable 2nd least stable

most stable….liquid

Crystallization in polymorphic systems

Ostwald (1897):

Etter (1991):

Another mechanism: Nucleation of one polymorph by another

Yu, L. J. Am. Chem. Soc. 2003, 125, 6380

c

c

(1) crystallizes first

(2) nucleates on while continues to grow

(3) grows faster

D-mannitol

CH2OH

HO-C-H

HO-C-H

H-C-OH

H-C-OH

CH2OH

CH2OH

HO-C-H

HO-C-H

H-C-OH

H-C-OH

CH2OH

Page 7: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

100 m100 m

100 m100 m

Other examples of cross-nucleation: ROY

Y04

R05

Chen, Xi, Yu JACS 2005

Other examples: Phenobarbital and carbamazepine/nicotinamide

100 μm

Phenobarbital Carbamazepine/Nicotinamide

Page 8: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

0.0

1.0

2.0

3.0

4.0

Y04 YT04 ON YN R OP R05 Y

r(

m/s

)

The new polymorph must grow faster than or as fast as the initial polymorph

Growth Rates of ROY at 27 ºC

Direction of cross nucleation: Y04 R, R05; R YN

ON, OP, YT04 Y

Crystallographic Data of ROY

Form YT04 Y ON OP R YN ORP

crystal sys. monoclinic monoclinic monoclinic monoclinic triclinic triclinic orthorhombic

space group P21/n P21/n P21/c P21/n P-1 P-1 Pbcadescription yellow

prismyellowprism

orangeneedle

orangeplate

redprism

yellowneedle

orange-redplate

a, Å 8.2324 8.5001 3.9453 7.9760 7.4918 4.5918 13.177b, Å 11.8173 16.413 18.685 13.319 7.7902 11.249 8.0209c, Å 12.3121 8.5371 16.3948 11.676 11.9110 12.315 22.801 ° 90 90 90 90 75.494 71.194 90

° 102.505 91.767 93.830 104.683 77.806 89.852 90

° 90 90 90 90 63.617 88.174 90

volume, Å3 1169.36 1190.5 1205.9 1199.9 598.88 601.85 2409.8Z 4 4 4 4 2 2 8Dcal, gcm-3 1.473 1.447 1.428 1.435 1.438 1.431 1.429

No apparent lattice matching exists between cross-nucleating structures

Page 9: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

-0.5

0

0.5

1

1.5

2

340 360 380 400 420 440T , K

G-G

β, k

J/m

ole

L

Tm

Tm

Tm

-0.5

0

0.5

1

1.5

2

340 360 380 400 420 440T , K

G-G

β, k

J/m

ole

L

Tm

Tm

Tm

The less stable polymorph can nucleate the more stable () and vice versa ().

-0.4

0

0.4

0.8

1.2

30 50 70 90 110

T, C

G-G

Y, k

J/m

ol

YN

L-scR

YT04ON

ON

OP

OP

Y

Y

L

ROYD-mannitol

Cross-nucleation rate depends on temperature

115 °C

100 °C105 °C

110 °CCross-nucleation

“Waiting time”

D-m

anni

tol/P

VP

Page 10: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

0

10

20

30

40

50

60

70

0 30 60 90 120 150 180 210 240 270 300

0

10

20

30

40

50

60

70

0 4 8 12 16 20 24 28

107 C

109 C

111 C

0

10

20

30

40

50

60

0 60 120 180 240 300 360 420 480 540 600

A Poisson process: “Waiting time” to the first success has exponential distribution

Cou

ntC

ount

Cou

nt

, 10-9 m2s

, 10-9 m2s

, 10-9 m2s

<> = 3.3 x 10-9 m2s

<> = 27 x 10-9 m2s

<> = 71 x 10-9 m2s

12

1: 1st success2: 2nd success

Cross-nucleation in seeded crystallization

spacer (0.15 mm thick)

melt

seedfiber loop

Polymorphs identified by Raman microscopy, XRD

seed side-on

[001]

100 m

100 m

seed end-on

[001]

D-mannitol at 140 ºC

Tao, J.; Yu, L. Cryst. Growth Des. 2007, 7, 2410

Page 11: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

This talkCrystallization in polymorphic systems

(1) A new mechanism: Nucleation of one polymorph by another

(2) Hidden polymorph discovered by cross-nucleation

(3) Survival of the fittest polymorph: Fast nucleater vs. fast grower

Crystals of resolvable chiral molecules: a special case of polymorphs

S

R

S SS

S

R

SR

R

R

RS

S

S

S

R SR R

R

SR

R

RSRSRSRSSRSRSRSRRSRSRSRS

racemate or racemic compound

(RC)

SSRSRRRSSRRRSRSSRSSSRSRR

solid solution(SS)

cong

lom

erat

e (C

)

RRRRRRRRRRRR

SSSSSSSSSSSS

+

AR AS

racemic liquidR = R enantiomerS = S enantiomer

R

Scommon

rare

rarer

enantiomorphs

Page 12: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

racemic compound

solid solution of R and S

Liquid of R or S

Liquid of R and S (racemic) enantiomorph

O

S

N

O

A hidden polymorph discovered by seeding

R

S

Huang, Chen, Yu. JACS 2006

Fast nucleation, slow growth Slow nucleation,

fast growth

tazofelone (chiral drug)

SS-0.5 SS-0.5 AS RCI RCII

T/K 100 296 293 293 295

Space group (No.) P21/n (14) P21/n (14) P21 (4) P21/c (14) Pbca (61)

Crystal system Monoclinic Monoclinic Monoclinic Monoclinic Orthorhombic

a/Å 9.1969(9) 9.3882(14) 9.392 11.313 17.204

b/Å 10.9212(11) 10.9503(16) 10.962 17.082 11.287

c/Å 17.6758(17) 17.855(3) 17.823 19.324 18.860

β/ 93.1731(18) 93.766(3) 94.29 101.11 90

V/Å3 1772.7(3) 1831.6(5) 1829.8 3665 3662.2

Z 4 4 4 8 8

ρcalc/g cm-3 1.205 1.166 1.167 1.165 1.166

Crystallographic data of the racemic solid solution of R and S tazofelone

Page 13: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0

135

140

145

150

155

Tm,A

xR

T (

°C)

Tm,RCII

Tm,SS-0.5

Tm,RCI

Te,AR-RCITe,AR-RCII

Te,A ≈ 110°C

A Type 2 solid solutionmax. mp

at xR = 0.5

• Solid solutions of enantiomers are rare

• Occurrence in racemate-forming system is unprecedented

Free energies of TZF solid solutions

Yu, L., Huang, J., Jones J. K. J. Phys. Chem. B 2005, 109, 19915-19922.

intermediate stability/solubility

-1

0

1

2

3

4

5

360 380 400 420 440

T (K)

G

GR

CII

(kJ/

mol

)

AR, AS

RCII

RCI

Tt Tm, RCI

Tm, RCII

LRC

LR,LS

SS-0.5

SS-0.85

L-0.85, L-0.15

Page 14: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

-8

-7

-6

-5

-4

70 90 110 130 150

T, °C

Lo

gr

(m/s

)

RCI

SS-0.5

The solid solution could be discovered by seeding because it grows faster than the

racemic compound, despite its slow nucleation

More hidden polymorphs?

This talkCrystallization in polymorphic systems

(1) A new mechanism: Nucleation of one polymorph by another

(2) Hidden polymorph discovered by cross-nucleation

(3) Survival of the fittest polymorph: Fast nucleater vs. fast grower

Page 15: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

• The Use of Polymer Heteronuclei for Crystalline Polymorph Selection. Lang, Grzesiak and Matzger* J. Am. Chem. Soc. 2002, 124, 14834

• Nonphotochemical, Laser-Induced Nucleation of Supersaturated Aqueous Glycine Produces Unexpected Polymorph. Zaccaro, Matic, Myerson, and Garetz. Cryst. Growth & Design2001, 1, 5

It is common to treat polymorph control as a nucleation problem

• Seeding with a polymorph to grow the same

100 m100 m

100 m100 m

But it is also a growth problem

Y04: fast nucleater, slow grower

R05: slow nucleater, fast grower

Chen, Xi, Yu JACS 2005

Page 16: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

(P21/n) metastable (P31 or P31) stable

glycine grows 500 x faster than glycine in water at the same supersaturation (10 %)

(Chew et al. Cryst. Eng. Comm. 2007)

C

H2C

N

H

H

H

O

O

_+

Polymorphs can grow at very different rates

-11

-10

-9

-8

-7

-6

-5

-4

220 240 260 280 300 320 340 360 380

Growth rates between ROY polymorphs can differ by 1000 timesand change with temperature

Polymorphs of ROY

(1) R P-1mp 106.2 oC= 21.7° ROY

(6) ORP Pbcamp 97 ºC, = 39.4°

(4) OP P21/cmp 112.7 oC= 46.1°

(2) ON P21/cmp 114.8oC= 52.6°

(5) YN P-1, mp 99 ºC= 104.1°

(3) Y P21/cmp 109.8 oC= 104.7°

N

S

HNO O

C

N

CH3

J. Am. Chem. Soc.2000, 122, 585

100 m

Y04

R

RL

JACS 2005a

(9) YT04 P21/cmp 106.9oC = 112.8°

(7) RPL

JACS 2001

(8) Y04

R05

Y04

L

(10) R05

JACS 2005b

Sun, … J. Phys. Chem. B 2008, 112, 5594

T, K

YT04

ON

Log

u, (

m/s

)

Page 17: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

-6

-4

-2

0

2

3 3.2 3.4 3.6 3.8 4 4.2 4.4

Log

(s)

103/T, 1/K

● ON∆ YN□ R05+ YT04x Y R○ OP

α

u diffusionless growth

Tg = 259 K

u diffusion-controlled growth

No good explanations yet…For ROY, the fast growers can transition from diffusion-controlled to “diffusionless” growth

u : time required to add one layer of molecules to the crystal : time required for an average molecule in the liquid to reorient or diffuse its diameter

0

1

2

3

3 4 5 6 7 8 9 10

0

2

4

3 4 5 6 7 8 9 10

0

2

4

3 4 5 6 7 8 9 10

0

2

4

3 4 5 6 7 8 9 10

YN

ON

YT04

Y

0

2

4

3 4 5 6 7 8 9 10

OP

0

1

2

3 4 5 6 7 8 9 10

R

Diffusion-controlled

growth

Able to transition to

“diffusionless” growth

Center-of-mass radial distribution functions of ROY polymorphs

No.

of m

olec

ules

r, Å

Page 18: Crystallization in polymorphic systems - School of Pharmacy · Crystallization in polymorphic systems (1) A new mechanism: Nucleation of one polymorph by another (2) Hidden polymorph

liquid

A nucleus A crystal(fast nucleater)

B nucleus B crystal(fast grower)

If the fast grower is not the fast nucleater, it can still “win” by nucleating on an existing

polymorph

Summary

• Fast nucleater need not be fast grower

• Through cross-nucleation, a fast-growing polymorph can dominate the product

• Cross-nucleation helps discover a rare solid solution of enantiomers. It is the first example for a racemate-forming system

• The relative growth rates of polymorphs is an important unsolved (likely solvable) problem